Header Logo

Connection

RANDAL S WEBER to Humans

Back to Details
This is a "connection" page, showing publications RANDAL S WEBER has written about Humans.
RANDAL S WEBER
Connection Strength
1.199
Humans
  1. Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisis. Head Neck. 2020 Jul; 42(7):1477-1481.
    View in: PubMed
    Score: 0.015
  2. Surgical management of non melanoma skin cancer of the head and neck. Oral Oncol. 2020 01; 100:104485.
    View in: PubMed
    Score: 0.014
  3. Prognostic performance of the American Joint Committee on Cancer 8th edition of the TNM staging system in patients with early oral tongue cancer. Head Neck. 2019 05; 41(5):1270-1276.
    View in: PubMed
    Score: 0.013
  4. Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck. 2019 01; 41(1):177-184.
    View in: PubMed
    Score: 0.013
  5. Multidisciplinary Team Planning for Patients with Head and Neck Cancer. Oral Maxillofac Surg Clin North Am. 2018 Nov; 30(4):435-444.
    View in: PubMed
    Score: 0.013
  6. Performance Improvement in Head and Neck Cancer. Curr Oncol Rep. 2018 01 19; 20(1):1.
    View in: PubMed
    Score: 0.012
  7. It Takes a Village: The Importance of Multidisciplinary Care. Otolaryngol Clin North Am. 2017 Aug; 50(4):679-687.
    View in: PubMed
    Score: 0.012
  8. Has the Pendulum Swung Back to Surgery First for Oropharyngeal Cancer? J Oncol Pract. 2016 11; 12(11):1189-1191.
    View in: PubMed
    Score: 0.011
  9. Addendum to Bell et al's "In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type". Cancer. 2016 07 15; 122(14):2278-9.
    View in: PubMed
    Score: 0.011
  10. Surgery for Malignant Submandibular Gland Neoplasms. Adv Otorhinolaryngol. 2016; 78:104-12.
    View in: PubMed
    Score: 0.011
  11. Development and Feasibility of a Specialty-Specific National Surgical Quality Improvement Program (NSQIP): The Head and Neck-Reconstructive Surgery NSQIP. JAMA Otolaryngol Head Neck Surg. 2016 Apr; 142(4):321-7.
    View in: PubMed
    Score: 0.011
  12. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer. 2016 May 15; 122(10):1513-22.
    View in: PubMed
    Score: 0.011
  13. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma. JAMA Otolaryngol Head Neck Surg. 2016 Mar; 142(3):234-40.
    View in: PubMed
    Score: 0.011
  14. Regarding ACR Appropriateness Criteria? aggressive nonmelanomatous skin cancer of the head and neck. Head Neck. 2016 Feb; 38(2):183.
    View in: PubMed
    Score: 0.011
  15. Improving patient outcomes through multidisciplinary treatment planning conference. Head Neck. 2016 04; 38 Suppl 1:E1820-5.
    View in: PubMed
    Score: 0.011
  16. Primary intraosseous mucoepidermoid carcinoma of the jaw: Reappraisal of The MD Anderson Cancer Center experience. Head Neck. 2016 04; 38 Suppl 1:E1312-7.
    View in: PubMed
    Score: 0.011
  17. An audit and feedback system for effective quality improvement in head and neck surgery: Can we become better surgeons? Cancer. 2015 May 15; 121(10):1581-7.
    View in: PubMed
    Score: 0.010
  18. Analysis of Charges Associated with Definitive Nonsurgical Therapy for Early-Stage Lateralized Tonsil Cancer. Ann Surg Oncol. 2015 Aug; 22(8):2755-60.
    View in: PubMed
    Score: 0.010
  19. Standardizing treatment: a crisis in cancer care. Otolaryngol Clin North Am. 2013 Aug; 46(4):671-9.
    View in: PubMed
    Score: 0.009
  20. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Mar 01; 18(5):1435-46.
    View in: PubMed
    Score: 0.008
  21. Concurrent chemoradiation for adenoid cystic carcinoma of the head and neck. Head Neck. 2012 Sep; 34(9):1263-8.
    View in: PubMed
    Score: 0.008
  22. The head and neck surgeon as clinician-investigator: opportunities and imperatives. The Hayes Martin Lecture. Arch Otolaryngol Head Neck Surg. 2011 Nov; 137(11):1079-85.
    View in: PubMed
    Score: 0.008
  23. Quality indicators in head and neck operations: a comparison with published benchmarks. Arch Otolaryngol Head Neck Surg. 2011 Nov; 137(11):1086-93.
    View in: PubMed
    Score: 0.008
  24. The results of temporal bone surgery for advanced or recurrent tumors of the parotid gland. Laryngoscope. 2011 Aug; 121(8):1702-7.
    View in: PubMed
    Score: 0.008
  25. The nature and extent of body image concerns among surgically treated patients with head and neck cancer. Psychooncology. 2012 Aug; 21(8):836-44.
    View in: PubMed
    Score: 0.008
  26. Anaplastic thyroid carcinoma: palliation or treatment? Curr Opin Otolaryngol Head Neck Surg. 2011 Apr; 19(2):113-8.
    View in: PubMed
    Score: 0.008
  27. Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. Am J Pathol. 2011 Feb; 178(2):548-71.
    View in: PubMed
    Score: 0.008
  28. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1205-11.
    View in: PubMed
    Score: 0.008
  29. Quality and performance indicators in an academic department of head and neck surgery. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1212-8.
    View in: PubMed
    Score: 0.008
  30. To TORS or Not to TORS: but is that the question? Comment on "transoral robotic surgery for advanced oropharyngeal carcinoma". Arch Otolaryngol Head Neck Surg. 2010 Nov; 136(11):1085-7.
    View in: PubMed
    Score: 0.008
  31. The impact of radiotherapy on facial nerve repair. Laryngoscope. 2010 Oct; 120(10):1985-9.
    View in: PubMed
    Score: 0.008
  32. Compliance with quality assurance measures in patients treated for early oral tongue cancer. Cancer. 2010 Jul 15; 116(14):3408-16.
    View in: PubMed
    Score: 0.007
  33. Outcomes of pediatric patients with malignancies of the major salivary glands. Ann Surg Oncol. 2010 Dec; 17(12):3301-7.
    View in: PubMed
    Score: 0.007
  34. Social challenges of cancer patients with orbitofacial disfigurement. Ophthalmic Plast Reconstr Surg. 2010 Jan-Feb; 26(1):18-22.
    View in: PubMed
    Score: 0.007
  35. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009 Dec 15; 115(24):5723-33.
    View in: PubMed
    Score: 0.007
  36. Predictors of level V metastasis in well-differentiated thyroid cancer. Head Neck. 2008 Nov; 30(11):1469-74.
    View in: PubMed
    Score: 0.007
  37. Parathyroid surgery: what the radiologists need to know. Neuroimaging Clin N Am. 2008 Aug; 18(3):551-8, ix.
    View in: PubMed
    Score: 0.006
  38. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment? J Natl Cancer Inst. 2008 May 21; 100(10):688-9.
    View in: PubMed
    Score: 0.006
  39. Management of locally invasive well-differentiated thyroid cancer. Surg Oncol Clin N Am. 2008 Jan; 17(1):145-55, ix.
    View in: PubMed
    Score: 0.006
  40. Improving the quality of head and neck cancer care. Arch Otolaryngol Head Neck Surg. 2007 Dec; 133(12):1188-92.
    View in: PubMed
    Score: 0.006
  41. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol. 2008 Jan; 15(1):34-45.
    View in: PubMed
    Score: 0.006
  42. Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. Arch Otolaryngol Head Neck Surg. 2007 Jun; 133(6):546-50.
    View in: PubMed
    Score: 0.006
  43. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer. 2007 May 15; 109(10):2052-7.
    View in: PubMed
    Score: 0.006
  44. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1102-9.
    View in: PubMed
    Score: 0.006
  45. Radiation-induced xerostomia. Head Neck. 2007 Jan; 29(1):58-63.
    View in: PubMed
    Score: 0.006
  46. Swing of the surgical pendulum: a return to surgery for treatment of head and neck cancer in the 21st century? Int J Radiat Oncol Biol Phys. 2007; 69(2 Suppl):S129-31.
    View in: PubMed
    Score: 0.006
  47. Isolated cervical esophageal reconstruction for rare esophageal tumors. Head Neck. 2006 Sep; 28(9):856-60.
    View in: PubMed
    Score: 0.006
  48. Use of the photonic band gap fiber assembly CO2 laser system in head and neck surgical oncology. Laryngoscope. 2006 Jul; 116(7):1288-90.
    View in: PubMed
    Score: 0.006
  49. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol Head Neck Surg. 2006 Jul; 132(7):779-82.
    View in: PubMed
    Score: 0.006
  50. Postoperative treatment intensification for improving outcome in the high-risk patient: an evolutionary process. Head Neck. 2005 Oct; 27(10):841-2.
    View in: PubMed
    Score: 0.005
  51. Foreword. Curr Probl Cancer. 2005 Jul-Aug; 29(4):168.
    View in: PubMed
    Score: 0.005
  52. Organ-preservation laryngeal surgery in the era of chemoradiation. Curr Probl Cancer. 2005 Jul-Aug; 29(4):169-79.
    View in: PubMed
    Score: 0.005
  53. The current role of vertical partial laryngectomy and open supraglottic laryngectomy. Curr Probl Cancer. 2005 Jul-Aug; 29(4):201-14.
    View in: PubMed
    Score: 0.005
  54. Craniofacial resection for nonmelanoma skin cancer of the head and neck. Laryngoscope. 2005 Jun; 115(6):931-7.
    View in: PubMed
    Score: 0.005
  55. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol. 2005 May 01; 23(13):3008-15.
    View in: PubMed
    Score: 0.005
  56. Intensity-modulated radiotherapy: is xerostomia still prevalent? Curr Oncol Rep. 2005 Mar; 7(2):131-6.
    View in: PubMed
    Score: 0.005
  57. High-risk non-melanoma skin cancer of the head and neck. Curr Oncol Rep. 2005 Mar; 7(2):154-8.
    View in: PubMed
    Score: 0.005
  58. Contemporary management of differentiated thyroid carcinoma. Otolaryngol Clin North Am. 2005 Feb; 38(1):161-78, x.
    View in: PubMed
    Score: 0.005
  59. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg. 2004 Oct; 131(4):472-6.
    View in: PubMed
    Score: 0.005
  60. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg. 2004 Oct; 130(10):1214-6.
    View in: PubMed
    Score: 0.005
  61. Controversies in the management of advanced laryngeal squamous cell carcinoma. Cancer. 2004 Jul 15; 101(2):211-9.
    View in: PubMed
    Score: 0.005
  62. Insular carcinoma of the thyroid with jugular vein invasion. Head Neck. 2004 Jul; 26(7):642-6.
    View in: PubMed
    Score: 0.005
  63. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2004 Jul; 130(7):857-60.
    View in: PubMed
    Score: 0.005
  64. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):72-7.
    View in: PubMed
    Score: 0.005
  65. Nonsurgical treatment of laryngeal cancer. N Engl J Med. 2004 Mar 04; 350(10):1049-53; author reply 1049-53.
    View in: PubMed
    Score: 0.005
  66. Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope. 2004 Mar; 114(3):403-6.
    View in: PubMed
    Score: 0.005
  67. Validation of a transfusion prediction model in head and neck cancer surgery. Arch Otolaryngol Head Neck Surg. 2003 Dec; 129(12):1297-302.
    View in: PubMed
    Score: 0.005
  68. Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis. Mod Pathol. 2024 Jan; 37(1):100372.
    View in: PubMed
    Score: 0.005
  69. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003 Jan; 129(1):44-9.
    View in: PubMed
    Score: 0.004
  70. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol. 2023 Apr; 30(4):2331-2338.
    View in: PubMed
    Score: 0.004
  71. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2023 07 01; 116(3):533-543.
    View in: PubMed
    Score: 0.004
  72. Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol. 2022 11; 134:106127.
    View in: PubMed
    Score: 0.004
  73. Craniofacial resection of advanced juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg. 2002 Sep; 128(9):1071-8.
    View in: PubMed
    Score: 0.004
  74. Design and impact of intraoperative pathways for head and neck resection and reconstruction. Arch Otolaryngol Head Neck Surg. 2002 Aug; 128(8):892-6.
    View in: PubMed
    Score: 0.004
  75. Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma. Surg Oncol. 2022 Sep; 44:101804.
    View in: PubMed
    Score: 0.004
  76. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope. 2002 Jul; 112(7 Pt 1):1209-12.
    View in: PubMed
    Score: 0.004
  77. Impact of age on clinical care pathway length of stay after complex head and neck resection. Head Neck. 2002 Jun; 24(6):545-8; discussion 545.
    View in: PubMed
    Score: 0.004
  78. Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival. Oral Oncol. 2022 07; 130:105906.
    View in: PubMed
    Score: 0.004
  79. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg. 2002 May; 128(5):521-6.
    View in: PubMed
    Score: 0.004
  80. Outcomes after definitive surgery for mandibular osteoradionecrosis. Head Neck. 2022 06; 44(6):1313-1323.
    View in: PubMed
    Score: 0.004
  81. Clinical care pathway for head and neck cancer: a valuable tool for decreasing resource utilization. Arch Otolaryngol Head Neck Surg. 2002 Mar; 128(3):258-62.
    View in: PubMed
    Score: 0.004
  82. Soft tissue sarcoma. Head Neck. 2002 Mar; 24(3):296-300.
    View in: PubMed
    Score: 0.004
  83. NCCN Guidelines? Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw. 2022 03; 20(3):224-234.
    View in: PubMed
    Score: 0.004
  84. Decannulation protocol for short term tracheostomy in pediatric head and neck tumor patients. Int J Pediatr Otorhinolaryngol. 2022 Feb; 153:111012.
    View in: PubMed
    Score: 0.004
  85. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment. Am J Otolaryngol. 2001 Sep-Oct; 22(5):329-35.
    View in: PubMed
    Score: 0.004
  86. Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer. 2021 12 01; 127(23):4413-4420.
    View in: PubMed
    Score: 0.004
  87. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 2021 08 15; 27(16):4557-4565.
    View in: PubMed
    Score: 0.004
  88. Internal jugular vein versus external jugular vein anastamosis: implications for successful free tissue transfer. Head Neck. 2001 Jun; 23(6):475-8.
    View in: PubMed
    Score: 0.004
  89. The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer. J Geriatr Oncol. 2021 07; 12(6):937-944.
    View in: PubMed
    Score: 0.004
  90. Comparison of Internal Patient Satisfaction Scores at a Cancer Center With Star Ratings on Online Physician-Rating Websites. JCO Oncol Pract. 2021 08; 17(8):e1181-e1188.
    View in: PubMed
    Score: 0.004
  91. Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes. Cancer. 2021 06 15; 127(12):1984-1992.
    View in: PubMed
    Score: 0.004
  92. The tumor immune contexture of salivary duct carcinoma. Head Neck. 2021 04; 43(4):1213-1219.
    View in: PubMed
    Score: 0.004
  93. Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck. Head Neck. 2021 05; 43(5):1592-1603.
    View in: PubMed
    Score: 0.004
  94. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. Eur J Cancer. 2021 02; 144:169-177.
    View in: PubMed
    Score: 0.004
  95. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer. 2021 04 15; 127(8):1238-1245.
    View in: PubMed
    Score: 0.004
  96. von Ebner's glands intercalated duct adenocarcinoma with PALB2 gene mutation. Ann Diagn Pathol. 2020 Dec; 49:151637.
    View in: PubMed
    Score: 0.004
  97. Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma. Am J Clin Oncol. 2000 Oct; 23(5):509-15.
    View in: PubMed
    Score: 0.004
  98. Enhanced Recovery After Surgery (ERAS) in Head and Neck Oncologic Surgery: A Case-Matched Analysis of Perioperative and Pain Outcomes. Ann Surg Oncol. 2021 Feb; 28(2):867-876.
    View in: PubMed
    Score: 0.004
  99. Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center. Cancer. 2020 11 15; 126(22):4905-4916.
    View in: PubMed
    Score: 0.004
  100. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol. 2020 Dec; 49:151622.
    View in: PubMed
    Score: 0.004
  101. Morbidity after midline mandibulotomy and radiation therapy. Am J Otolaryngol. 2000 Sep-Oct; 21(5):312-7.
    View in: PubMed
    Score: 0.004
  102. Feasibility of an Enhanced Recovery After Surgery (ERAS) pathway for major head and neck oncologic surgery. Am J Otolaryngol. 2020 Nov - Dec; 41(6):102679.
    View in: PubMed
    Score: 0.004
  103. Risk-adjustment models in patients undergoing head and neck surgery with reconstruction. Oral Oncol. 2020 12; 111:104917.
    View in: PubMed
    Score: 0.004
  104. Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer. Cancer. 2020 10 01; 126(19):4304-4314.
    View in: PubMed
    Score: 0.004
  105. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 07; 18(7):873-898.
    View in: PubMed
    Score: 0.004
  106. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
    View in: PubMed
    Score: 0.004
  107. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg. 2020 02 01; 146(2):128-135.
    View in: PubMed
    Score: 0.004
  108. Marking two decades of publication and on to the new millennium. Head Neck. 1999 Dec; 21(8):685-8.
    View in: PubMed
    Score: 0.004
  109. ASO Author Reflections: Unplanned Return to the Operating Room: Implementing a Specialty-Specific NSQIP in Patients Undergoing Head and Neck Surgery with Free Flap Reconstruction. Ann Surg Oncol. 2020 Feb; 27(2):449-450.
    View in: PubMed
    Score: 0.004
  110. Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer. Head Neck. 2019 11; 41(11):3960-3969.
    View in: PubMed
    Score: 0.003
  111. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch. 2020 Feb; 476(2):295-305.
    View in: PubMed
    Score: 0.003
  112. Evaluating Unplanned Returns to the Operating Room in Head and Neck Free Flap Patients. Ann Surg Oncol. 2020 Feb; 27(2):440-448.
    View in: PubMed
    Score: 0.003
  113. Reducing patient wait times in a head and neck cancer outpatient clinic: A pilot study. Laryngoscope. 2020 04; 130(4):E151-E154.
    View in: PubMed
    Score: 0.003
  114. Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis. Ann Diagn Pathol. 2019 Aug; 41:14-23.
    View in: PubMed
    Score: 0.003
  115. Nerve cell adhesion molecule expression in squamous cell carcinoma of the head and neck: a predictor of propensity toward perineural spread. Laryngoscope. 1999 May; 109(5):821-6.
    View in: PubMed
    Score: 0.003
  116. Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. Head Neck. 2019 09; 41(9):3090-3104.
    View in: PubMed
    Score: 0.003
  117. PD-L1 expression by immunohistochemistry in salivary duct carcinoma. Ann Diagn Pathol. 2019 Jun; 40:49-52.
    View in: PubMed
    Score: 0.003
  118. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. Cancer. 2019 06 15; 125(12):2027-2038.
    View in: PubMed
    Score: 0.003
  119. Malignant tumors of the nose and paranasal sinuses: hospital of the University of Pennsylvania experience 1990-1997. Am J Rhinol. 1999 Mar-Apr; 13(2):117-23.
    View in: PubMed
    Score: 0.003
  120. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019 06 01; 125(11):1823-1829.
    View in: PubMed
    Score: 0.003
  121. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Laryngoscope. 2020 01; 130(1):146-153.
    View in: PubMed
    Score: 0.003
  122. Primary Malignant Thyroid Teratoma: An Institutional Experience. Thyroid. 2019 02; 29(2):229-236.
    View in: PubMed
    Score: 0.003
  123. Management of patients after elective carotid artery resection. Am J Otolaryngol. 1999 Jan-Feb; 20(1):37-42.
    View in: PubMed
    Score: 0.003
  124. Synchronous schwannomas of the hypoglossal nerve and cervical sympathetic chain. AJR Am J Roentgenol. 1998 Dec; 171(6):1505-7.
    View in: PubMed
    Score: 0.003
  125. In Regard to Bossi et?al. Int J Radiat Oncol Biol Phys. 2018 11 01; 102(3):669-670.
    View in: PubMed
    Score: 0.003
  126. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654.
    View in: PubMed
    Score: 0.003
  127. Primary malignant teratoma of the thyroid gland: report and discussion of two cases. Head Neck. 1998 Oct; 20(7):649-53.
    View in: PubMed
    Score: 0.003
  128. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. 2018 09 15; 124(18):3693-3705.
    View in: PubMed
    Score: 0.003
  129. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. 2018 09; 40(9):2060-2069.
    View in: PubMed
    Score: 0.003
  130. Incompletely treated malignancies of the major salivary gland: Toward evidence-based care. Head Neck. 2018 08; 40(8):1630-1638.
    View in: PubMed
    Score: 0.003
  131. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018 05; 16(5):479-490.
    View in: PubMed
    Score: 0.003
  132. Neoplastic fixation to the prevertebral compartment by squamous cell carcinoma of the head and neck. AJR Am J Roentgenol. 1998 May; 170(5):1389-94.
    View in: PubMed
    Score: 0.003
  133. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol. 2018 04; 79:1-8.
    View in: PubMed
    Score: 0.003
  134. Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program. J Oncol Pract. 2018 02; 14(2):e103-e112.
    View in: PubMed
    Score: 0.003
  135. Wound infection in head and neck surgery: implications for perioperative antibiotic treatment. Ear Nose Throat J. 1997 Nov; 76(11):790-1, 795-8.
    View in: PubMed
    Score: 0.003
  136. Cellular subtype may predict survival outcomes in salivary adenoid cystic carcinoma patients-a single-institution experience. Virchows Arch. 2018 Mar; 472(3):505-512.
    View in: PubMed
    Score: 0.003
  137. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
    View in: PubMed
    Score: 0.003
  138. Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades. Dysphagia. 2018 04; 33(2):185-191.
    View in: PubMed
    Score: 0.003
  139. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017 Dec 20; 35(36):4057-4065.
    View in: PubMed
    Score: 0.003
  140. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck?Cancer. Int J Radiat Oncol Biol Phys. 2017 08 01; 98(5):1002-1011.
    View in: PubMed
    Score: 0.003
  141. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 06; 15(6):761-770.
    View in: PubMed
    Score: 0.003
  142. Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association. Hum Pathol. 2017 10; 68:189-192.
    View in: PubMed
    Score: 0.003
  143. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck. 2017 08; 39(8):1609-1620.
    View in: PubMed
    Score: 0.003
  144. Establishment and genomic characterization of primary salivary duct carcinoma cell line. Oral Oncol. 2017 06; 69:108-114.
    View in: PubMed
    Score: 0.003
  145. Thyroid carcinoma. Cancer Treat Res. 1997; 90:149-69.
    View in: PubMed
    Score: 0.003
  146. Complications, hospital length of stay, and readmission after total laryngectomy. Cancer. 2017 05 15; 123(10):1760-1767.
    View in: PubMed
    Score: 0.003
  147. Prognostic factors affecting outcome in lower gingival carcinoma. Laryngoscope. 1996 Nov; 106(11):1335-9.
    View in: PubMed
    Score: 0.003
  148. Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation. Cancer. 2017 Jan 01; 123(1):62-70.
    View in: PubMed
    Score: 0.003
  149. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):687-699.
    View in: PubMed
    Score: 0.003
  150. Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer. Chin Clin Oncol. 2016 Aug; 5(4):54.
    View in: PubMed
    Score: 0.003
  151. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016 12; 38(12):1739-1751.
    View in: PubMed
    Score: 0.003
  152. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):667-677.
    View in: PubMed
    Score: 0.003
  153. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016 Nov 15; 122(21):3307-3315.
    View in: PubMed
    Score: 0.003
  154. Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture. Head Neck. 2016 12; 38(12):1765-1771.
    View in: PubMed
    Score: 0.003
  155. Lower gingival carcinoma. Clinical and pathologic determinants of regional metastases. Arch Otolaryngol Head Neck Surg. 1996 Jun; 122(6):634-8.
    View in: PubMed
    Score: 0.003
  156. Surgical management of cervical lymph node metastases. Curr Opin Oncol. 1996 May; 8(3):215-20.
    View in: PubMed
    Score: 0.003
  157. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1117-31.
    View in: PubMed
    Score: 0.003
  158. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head Neck. 2016 04; 38 Suppl 1:E2091-9.
    View in: PubMed
    Score: 0.003
  159. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck. 2016 04; 38 Suppl 1:E1962-8.
    View in: PubMed
    Score: 0.003
  160. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res. 2016 Feb 01; 22(3):725-33.
    View in: PubMed
    Score: 0.003
  161. Quality assessment in head and neck oncologic surgery in a Brazilian cancer center compared with MD Anderson Cancer Center benchmarks. Head Neck. 2016 07; 38(7):1002-7.
    View in: PubMed
    Score: 0.003
  162. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016 Feb 15; 122(4):546-58.
    View in: PubMed
    Score: 0.003
  163. Split-thickness skin graft donor site management. A randomized prospective trial comparing a hydrophilic polyurethane absorbent foam dressing with a petrolatum gauze dressing. Arch Otolaryngol Head Neck Surg. 1995 Oct; 121(10):1145-9.
    View in: PubMed
    Score: 0.003
  164. Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes. J Clin Oncol. 2015 Oct 10; 33(29):3262-8.
    View in: PubMed
    Score: 0.003
  165. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma. Head Neck. 2016 06; 38(6):886-93.
    View in: PubMed
    Score: 0.003
  166. A model for predicting transfusion requirements in head and neck surgery. Laryngoscope. 1995 Aug; 105(8 Pt 2 Suppl 73):1-17.
    View in: PubMed
    Score: 0.003
  167. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016 04; 38 Suppl 1:E2259-66.
    View in: PubMed
    Score: 0.003
  168. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):847-55; quiz 856.
    View in: PubMed
    Score: 0.003
  169. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biol Ther. 2015; 16(6):834-8.
    View in: PubMed
    Score: 0.003
  170. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
    View in: PubMed
    Score: 0.003
  171. Cutaneous malignancy of the head and neck. Surg Oncol Clin N Am. 2015 Jul; 24(3):593-613.
    View in: PubMed
    Score: 0.003
  172. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol. 2015 Jun; 19(3):154-6.
    View in: PubMed
    Score: 0.003
  173. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015 Jun; 51(6):610-5.
    View in: PubMed
    Score: 0.003
  174. Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands. Ann Surg Oncol. 2015 Oct; 22(11):3701-7.
    View in: PubMed
    Score: 0.003
  175. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey. Cancer. 2015 May 15; 121(10):1608-19.
    View in: PubMed
    Score: 0.003
  176. Elective modified neck dissection for treatment of the clinically negative (N0) neck. Cancer Treat Res. 1995; 74:221-41.
    View in: PubMed
    Score: 0.003
  177. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response. Oral Oncol. 2015 Feb; 51(2):195-201.
    View in: PubMed
    Score: 0.003
  178. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014 Dec 01; 32(34):3858-66.
    View in: PubMed
    Score: 0.002
  179. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81.
    View in: PubMed
    Score: 0.002
  180. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 Dec 15; 20(24):6582-92.
    View in: PubMed
    Score: 0.002
  181. Two perplexing skin tumors: microcystic adnexal carcinoma and keratoacanthoma. Ann Otol Rhinol Laryngol. 1994 Oct; 103(10):829-32.
    View in: PubMed
    Score: 0.002
  182. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1454-87.
    View in: PubMed
    Score: 0.002
  183. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50.
    View in: PubMed
    Score: 0.002
  184. Development and characterization of salivary adenoid cystic carcinoma cell line. Oral Oncol. 2014 Oct; 50(10):991-9.
    View in: PubMed
    Score: 0.002
  185. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):846-53.
    View in: PubMed
    Score: 0.002
  186. Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomes. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):410-5.
    View in: PubMed
    Score: 0.002
  187. Bacteriologic profile of surgical infection after antibiotic prophylaxis. Head Neck. 1993 Nov-Dec; 15(6):526-31.
    View in: PubMed
    Score: 0.002
  188. Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1195-202.
    View in: PubMed
    Score: 0.002
  189. The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer. 2014 May 01; 120(9):1361-8.
    View in: PubMed
    Score: 0.002
  190. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. Ann Diagn Pathol. 2014 Feb; 18(1):10-3.
    View in: PubMed
    Score: 0.002
  191. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Aug; 11(8):917-23.
    View in: PubMed
    Score: 0.002
  192. Reply to e.g. Russi et Al and R. Haddad. J Clin Oncol. 2013 Sep 01; 31(25):3171.
    View in: PubMed
    Score: 0.002
  193. Metastatic thyroid cancer. Head Neck. 1993 Jul-Aug; 15(4):357-8.
    View in: PubMed
    Score: 0.002
  194. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778.
    View in: PubMed
    Score: 0.002
  195. Primary sarcomas of the salivary glands: case series and literature review. Head Neck. 2013 Nov; 35(11):1551-7.
    View in: PubMed
    Score: 0.002
  196. Developing a system to track meaningful outcome measures in head and neck cancer treatment. Head Neck. 2014 Feb; 36(2):226-30.
    View in: PubMed
    Score: 0.002
  197. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57.
    View in: PubMed
    Score: 0.002
  198. Complications of surgery of the thyroid and parathyroid glands. Surg Clin North Am. 1993 Apr; 73(2):307-21.
    View in: PubMed
    Score: 0.002
  199. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol. 2013 Jan 29; 8:21.
    View in: PubMed
    Score: 0.002
  200. Nonwound infections following head and neck oncologic surgery. Laryngoscope. 1993 Jan; 103(1 Pt 1):22-7.
    View in: PubMed
    Score: 0.002
  201. Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx, and cervical esophagus. Otolaryngol Head Neck Surg. 1993 Jan; 108(1):11-7.
    View in: PubMed
    Score: 0.002
  202. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013 Mar 01; 31(7):845-52.
    View in: PubMed
    Score: 0.002
  203. Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):983-9.
    View in: PubMed
    Score: 0.002
  204. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg. 1992 Nov; 118(11):1159-63.
    View in: PubMed
    Score: 0.002
  205. Metastatic thyroid cancer as an incidental finding during neck dissection: significance and management. Head Neck. 1992 Nov-Dec; 14(6):459-63.
    View in: PubMed
    Score: 0.002
  206. Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck. 2012 Dec; 34(12):1681-703.
    View in: PubMed
    Score: 0.002
  207. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):941-7.
    View in: PubMed
    Score: 0.002
  208. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013 Jan 01; 119(1):81-9.
    View in: PubMed
    Score: 0.002
  209. ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma. Head Neck. 2013 Apr; 35(4):575-8.
    View in: PubMed
    Score: 0.002
  210. Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e367-74.
    View in: PubMed
    Score: 0.002
  211. Mucosal melanoma of the head and neck. J Natl Compr Canc Netw. 2012 Mar; 10(3):320-38.
    View in: PubMed
    Score: 0.002
  212. Level V in therapeutic neck dissections for papillary thyroid carcinoma. Head Neck. 2013 Apr; 35(4):605-7.
    View in: PubMed
    Score: 0.002
  213. Minor salivary gland malignancies in the pediatric population. Head Neck. 2012 Nov; 34(11):1648-51.
    View in: PubMed
    Score: 0.002
  214. Nasopharyngeal angiofibroma. Head Neck. 1992 Jan-Feb; 14(1):67-71.
    View in: PubMed
    Score: 0.002
  215. Antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery. Ann Otol Rhinol Laryngol Suppl. 1992 Jan; 155:16-20.
    View in: PubMed
    Score: 0.002
  216. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012 Aug 15; 118(16):3928-36.
    View in: PubMed
    Score: 0.002
  217. Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 2012 Jun 01; 118(11):2872-8.
    View in: PubMed
    Score: 0.002
  218. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011 Nov 15; 17(22):7003-14.
    View in: PubMed
    Score: 0.002
  219. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011 Oct 01; 12(7):569-73.
    View in: PubMed
    Score: 0.002
  220. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2011 Nov; 32(11):1668-74.
    View in: PubMed
    Score: 0.002
  221. Management of perineural invasion in sebaceous carcinoma of the eyelid. Ophthalmic Plast Reconstr Surg. 2011 Sep-Oct; 27(5):356-9.
    View in: PubMed
    Score: 0.002
  222. Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma. Cancer. 2012 Mar 01; 118(5):1288-92.
    View in: PubMed
    Score: 0.002
  223. Head and neck cancers. J Natl Compr Canc Netw. 2011 Jun 01; 9(6):596-650.
    View in: PubMed
    Score: 0.002
  224. Expression and regulation of the ?N and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings. Am J Pathol. 2011 Jul; 179(1):391-9.
    View in: PubMed
    Score: 0.002
  225. Functional results after total or near total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg. 1991 May; 117(5):512-5.
    View in: PubMed
    Score: 0.002
  226. Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head Neck. 2012 May; 34(5):727-35.
    View in: PubMed
    Score: 0.002
  227. Quality of care in head and neck cancer. Curr Oncol Rep. 2011 Apr; 13(2):120-5.
    View in: PubMed
    Score: 0.002
  228. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clin Cancer Res. 2011 Apr 01; 17(7):2035-43.
    View in: PubMed
    Score: 0.002
  229. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma. Head Neck. 2011 Feb; 33(2):189-98.
    View in: PubMed
    Score: 0.002
  230. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck. 2011 Dec; 33(12):1769-73.
    View in: PubMed
    Score: 0.002
  231. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer. 2011 Jul 01; 117(13):2898-909.
    View in: PubMed
    Score: 0.002
  232. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011 Jan; 137(1):78-81.
    View in: PubMed
    Score: 0.002
  233. Proposal for a rational classification of neck dissections. Head Neck. 2011 Mar; 33(3):445-50.
    View in: PubMed
    Score: 0.002
  234. Treatment selection for carcinoma of the base of the tongue. Am J Surg. 1990 Oct; 160(4):415-9.
    View in: PubMed
    Score: 0.002
  235. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer. 2010 Dec 15; 116(24):5749-56.
    View in: PubMed
    Score: 0.002
  236. Submandibular gland tumors. Adverse histologic factors and therapeutic implications. Arch Otolaryngol Head Neck Surg. 1990 Sep; 116(9):1055-60.
    View in: PubMed
    Score: 0.002
  237. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 01; 16(19):4722-31.
    View in: PubMed
    Score: 0.002
  238. Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization. Head Neck. 2010 Aug; 32(8):1118-24.
    View in: PubMed
    Score: 0.002
  239. Complications and functional outcomes following complex oropharyngeal reconstruction. Head Neck. 2010 Aug; 32(8):1003-11.
    View in: PubMed
    Score: 0.002
  240. Central compartment dissection in laryngeal cancer. Head Neck. 2011 May; 33(5):746-52.
    View in: PubMed
    Score: 0.002
  241. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010 Jul 01; 363(1):24-35.
    View in: PubMed
    Score: 0.002
  242. The emergence of endoscopic head and neck surgery. Curr Oncol Rep. 2010 May; 12(3):216-22.
    View in: PubMed
    Score: 0.002
  243. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res. 2010 Apr 15; 16(8):2266-74.
    View in: PubMed
    Score: 0.002
  244. Pharyngoesophageal reconstruction with the anterolateral thigh flap after total laryngopharyngectomy. Cancer. 2010 Apr 01; 116(7):1718-24.
    View in: PubMed
    Score: 0.002
  245. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1005-10.
    View in: PubMed
    Score: 0.002
  246. Transoral robotic free flap reconstruction of oropharyngeal defects: a preclinical investigation. Plast Reconstr Surg. 2010 Mar; 125(3):896-900.
    View in: PubMed
    Score: 0.002
  247. Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):667-74.
    View in: PubMed
    Score: 0.002
  248. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.002
  249. Advanced basal and squamous cell carcinomas of the skin of the head and neck. Cancer Treat Res. 1990; 52:61-81.
    View in: PubMed
    Score: 0.002
  250. Better than Buffett?: a report on the success of the American Head and Neck Society Research Grant Program. Arch Otolaryngol Head Neck Surg. 2009 Nov; 135(11):1082-6.
    View in: PubMed
    Score: 0.002
  251. Impact of reconstructive microsurgery in patients with advanced oral cavity cancers. Head Neck. 2009 Oct; 31(10):1289-96.
    View in: PubMed
    Score: 0.002
  252. Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. J Clin Oncol. 2009 Oct 01; 27(28):4727-32.
    View in: PubMed
    Score: 0.002
  253. Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study. Head Neck. 2009 Aug; 31(8):1031-8.
    View in: PubMed
    Score: 0.002
  254. Electrosurgical dissection to reduce blood loss in head and neck surgery. Head Neck. 1989 Jul-Aug; 11(4):318-24.
    View in: PubMed
    Score: 0.002
  255. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck. 2009 Jun; 31(6):748-58.
    View in: PubMed
    Score: 0.002
  256. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009 May 20; 27(15):2509-15.
    View in: PubMed
    Score: 0.002
  257. Minor salivary gland tumors of the lip and buccal mucosa. Laryngoscope. 1989 Jan; 99(1):6-9.
    View in: PubMed
    Score: 0.002
  258. Effect of epidermal growth factor (EGF) on a newly established head and neck squamous carcinoma cell line. Otolaryngol Head Neck Surg. 1988 Dec; 99(6):567-73.
    View in: PubMed
    Score: 0.002
  259. Head and neck cancer: an evolving treatment paradigm. Cancer. 2008 Oct 01; 113(7 Suppl):1911-32.
    View in: PubMed
    Score: 0.002
  260. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 2008 Nov 01; 26(31):5119-25.
    View in: PubMed
    Score: 0.002
  261. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008 Aug 15; 14(16):5181-7.
    View in: PubMed
    Score: 0.002
  262. Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1351-5.
    View in: PubMed
    Score: 0.002
  263. Head and neck cancers. J Natl Compr Canc Netw. 2008 Aug; 6(7):646-95.
    View in: PubMed
    Score: 0.002
  264. Squamous cell carcinoma of the soft palate, uvula, and anterior faucial pillar. Otolaryngol Head Neck Surg. 1988 Jul; 99(1):16-23.
    View in: PubMed
    Score: 0.002
  265. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008 Jul 20; 26(21):3582-9.
    View in: PubMed
    Score: 0.002
  266. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study. Cancer. 2008 Jun 15; 112(12):2698-709.
    View in: PubMed
    Score: 0.002
  267. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 2009 Feb 01; 73(2):399-409.
    View in: PubMed
    Score: 0.002
  268. The relationship of circulating IgA to cellular immunity in head and neck cancer patients. Laryngoscope. 1988 Jun; 98(6 Pt 1):671-8.
    View in: PubMed
    Score: 0.002
  269. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 2008 May 01; 112(9):2088-100.
    View in: PubMed
    Score: 0.002
  270. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res. 2008 May 01; 14(9):2664-72.
    View in: PubMed
    Score: 0.002
  271. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association. Genes Chromosomes Cancer. 2008 Apr; 47(4):309-14.
    View in: PubMed
    Score: 0.002
  272. Academic productivity in otolaryngology. Otolaryngol Head Neck Surg. 2008 Apr; 138(4):546; author reply 546-7.
    View in: PubMed
    Score: 0.002
  273. Treatment of head and neck cancer. N Engl J Med. 2008 Mar 06; 358(10):1076; author reply 1077-8.
    View in: PubMed
    Score: 0.002
  274. Recent advances in thyroid cancer. In brief. Curr Probl Surg. 2008 Mar; 45(3):149-51.
    View in: PubMed
    Score: 0.002
  275. Recent advances in thyroid cancer. Curr Probl Surg. 2008 Mar; 45(3):156-250.
    View in: PubMed
    Score: 0.002
  276. Videos in clinical medicine. Examination of the larynx and pharynx. N Engl J Med. 2008 Jan 17; 358(3):e2.
    View in: PubMed
    Score: 0.002
  277. Prevalence of human papillomavirus in inverted nasal papillomas. Arch Otolaryngol Head Neck Surg. 1988 Jan; 114(1):23-6.
    View in: PubMed
    Score: 0.002
  278. Renal-cell carcinoma with intranuclear inclusions metastatic to thyroid: a diagnostic problem in aspiration cytology. Diagn Cytopathol. 1988; 4(2):125-9.
    View in: PubMed
    Score: 0.002
  279. Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):401-6.
    View in: PubMed
    Score: 0.002
  280. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31.
    View in: PubMed
    Score: 0.002
  281. Ruptured pseudoaneurysm of the internal maxillary artery complicating CT-guided fine-needle aspiration in an irradiated, surgical bed. Head Neck. 2007 Dec; 29(12):1156-9.
    View in: PubMed
    Score: 0.002
  282. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 01; 13(21):6532-9.
    View in: PubMed
    Score: 0.002
  283. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol. 2007 Nov; 31(11):1645-52.
    View in: PubMed
    Score: 0.002
  284. Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue. Head Neck Pathol. 2007 Dec; 1(2):165-8.
    View in: PubMed
    Score: 0.002
  285. Epithelioid hemangioendothelioma of the head and neck: role of podoplanin in the differential diagnosis. Head Neck Pathol. 2008 Mar; 2(1):25-30.
    View in: PubMed
    Score: 0.002
  286. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
    View in: PubMed
    Score: 0.002
  287. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1369-76.
    View in: PubMed
    Score: 0.002
  288. Treatment of invasive Aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope. 1987 Aug; 97(8 Pt 1):937-41.
    View in: PubMed
    Score: 0.002
  289. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer. 2007 Apr 01; 109(7):1331-43.
    View in: PubMed
    Score: 0.001
  290. Split calvarium cranioplasty. Arch Otolaryngol Head Neck Surg. 1987 Jan; 113(1):84-9.
    View in: PubMed
    Score: 0.001
  291. The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium. Int J Radiat Oncol Biol Phys. 2007; 69(2 Suppl):S1-3.
    View in: PubMed
    Score: 0.001
  292. Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res. 2006 Dec 15; 12(24):7353-8.
    View in: PubMed
    Score: 0.001
  293. Standards for ethical publication. Otol Neurotol. 2006 Dec; 27(8):1049-50.
    View in: PubMed
    Score: 0.001
  294. Standards for ethical publication. J Voice. 2006 Dec; 20(4):485-6.
    View in: PubMed
    Score: 0.001
  295. Importance of patient examination to clinical quality assurance in head and neck radiation oncology. Head Neck. 2006 Nov; 28(11):967-73.
    View in: PubMed
    Score: 0.001
  296. Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):5960-71.
    View in: PubMed
    Score: 0.001
  297. Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg. 1986 Oct; 152(4):386-92.
    View in: PubMed
    Score: 0.001
  298. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006 Sep; 116(9 Pt 2 Suppl 111):1-13.
    View in: PubMed
    Score: 0.001
  299. Research education and training in otolaryngology: meeting summary and research opportunities. Otolaryngol Head Neck Surg. 2006 Sep; 135(3):361-7.
    View in: PubMed
    Score: 0.001
  300. Intensity-modulated radiation therapy and xerostomia. J Calif Dent Assoc. 2006 Sep; 34(9):743-8.
    View in: PubMed
    Score: 0.001
  301. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. J Invest Dermatol. 2007 Jan; 127(1):196-205.
    View in: PubMed
    Score: 0.001
  302. Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument. Am J Clin Oncol. 2006 Apr; 29(2):158-62.
    View in: PubMed
    Score: 0.001
  303. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck. 2006 Feb; 28(2):166-75.
    View in: PubMed
    Score: 0.001
  304. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.001
  305. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys. 2006 Mar 01; 64(3):678-83.
    View in: PubMed
    Score: 0.001
  306. Endoscopic rendezvous procedure for complete esophageal stenosis. Gastrointest Endosc. 2005 Oct; 62(4):647-8; author reply 648.
    View in: PubMed
    Score: 0.001
  307. Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Nat Clin Pract Oncol. 2005 Oct; 2(10):526-33.
    View in: PubMed
    Score: 0.001
  308. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005 Sep; 115(9):1561-7.
    View in: PubMed
    Score: 0.001
  309. Consortium of otolaryngology-head and neck surgery journals to collaborate in maintenance of high ethical standards. Audiol Neurootol. 2005 Nov-Dec; 10(6):303-4.
    View in: PubMed
    Score: 0.001
  310. Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease? Head Neck. 2005 Aug; 27(8):718-21.
    View in: PubMed
    Score: 0.001
  311. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005 Aug; 28(4):385-92.
    View in: PubMed
    Score: 0.001
  312. Clinical restoration of voice function after loss of the vagus nerve. Head Neck Surg. 1985 Jul-Aug; 7(6):448-57.
    View in: PubMed
    Score: 0.001
  313. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. Hum Pathol. 2005 Jul; 36(7):821-7.
    View in: PubMed
    Score: 0.001
  314. Elective and therapeutic selective neck dissection. Oral Oncol. 2006 Jan; 42(1):14-25.
    View in: PubMed
    Score: 0.001
  315. Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Hum Pathol. 2005 Jun; 36(6):670-5.
    View in: PubMed
    Score: 0.001
  316. Consortium of Otolaryngology-Head and Neck Surgery Journals to collaborate in maintenance of high ethical standards. Am J Rhinol. 2005 May-Jun; 19(3):227-8.
    View in: PubMed
    Score: 0.001
  317. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion! Oral Oncol. 2005 Jul; 41(6):580-8.
    View in: PubMed
    Score: 0.001
  318. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol. 2005 Mar; 18(3):315-9.
    View in: PubMed
    Score: 0.001
  319. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene. 2005 Feb 10; 24(7):1244-51.
    View in: PubMed
    Score: 0.001
  320. Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space. Head Neck. 2005 Feb; 27(2):95-100.
    View in: PubMed
    Score: 0.001
  321. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Semin Oncol. 2004 Dec; 31(6 Suppl 18):25-8.
    View in: PubMed
    Score: 0.001
  322. Sensorineural hearing loss associated with ulcerative colitis. A case report. Arch Otolaryngol. 1984 Dec; 110(12):810-2.
    View in: PubMed
    Score: 0.001
  323. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol. 2004 Oct; 28(10):1299-310.
    View in: PubMed
    Score: 0.001
  324. Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance. J Mol Diagn. 2004 Aug; 6(3):180-90.
    View in: PubMed
    Score: 0.001
  325. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004 Aug; 26(8):716-26.
    View in: PubMed
    Score: 0.001
  326. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res. 2004 Jun 01; 10(11):3825-30.
    View in: PubMed
    Score: 0.001
  327. Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx. AJNR Am J Neuroradiol. 2004 Jun-Jul; 25(6):1092-8.
    View in: PubMed
    Score: 0.001
  328. Technique of endoscopic retrograde puncture and dilatation of total esophageal stenosis in patients with radiation-induced strictures. Head Neck. 2004 Feb; 26(2):179-83.
    View in: PubMed
    Score: 0.001
  329. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003 Nov 27; 349(22):2091-8.
    View in: PubMed
    Score: 0.001
  330. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. Arch Pathol Lab Med. 2003 Nov; 127(11):1480-4.
    View in: PubMed
    Score: 0.001
  331. c-Met expression in tall cell variant papillary carcinoma of the thyroid. Cancer. 2003 Oct 01; 98(7):1386-93.
    View in: PubMed
    Score: 0.001
  332. Stomal recurrence: pathophysiology, treatment and prevention. Acta Otolaryngol. 2003 Apr; 123(3):421-32.
    View in: PubMed
    Score: 0.001
  333. Ectopic parathyroid adenoma initially suspected to be a thyroid lesion. Arch Pathol Lab Med. 2002 Dec; 126(12):1541-2.
    View in: PubMed
    Score: 0.001
  334. Comparison of endotracheal tube and hookwire electrodes for monitoring the vagus nerve. J Clin Monit Comput. 2002 Apr-May; 17(3-4):217-20.
    View in: PubMed
    Score: 0.001
  335. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res. 2002 Mar; 8(3):885-92.
    View in: PubMed
    Score: 0.001
  336. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck. 2002 Feb; 24(2):115-26.
    View in: PubMed
    Score: 0.001
  337. Tumor deposition of laminin-5 and the relationship with perineural invasion. Laryngoscope. 2001 Dec; 111(12):2140-3.
    View in: PubMed
    Score: 0.001
  338. Interinstitutional review of thyroid fine-needle aspirations: impact on clinical management of thyroid nodules. Diagn Cytopathol. 2001 Oct; 25(4):231-4.
    View in: PubMed
    Score: 0.001
  339. Feasibility and outcome of endoscopic staple-assisted esophagodiverticulostomy for Zenker's diverticulum. Laryngoscope. 2001 Sep; 111(9):1506-8.
    View in: PubMed
    Score: 0.001
  340. Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 2001 Mar 01; 19(5):1363-73.
    View in: PubMed
    Score: 0.001
  341. Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):39-43.
    View in: PubMed
    Score: 0.001
  342. Synchronous appearance of germ cell tumor and papillary carcinoma of the thyroid. Am J Otolaryngol. 2000 Nov-Dec; 21(6):416-20.
    View in: PubMed
    Score: 0.001
  343. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 2000 Apr 01; 60(7):2018-24.
    View in: PubMed
    Score: 0.001
  344. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: mimic of Hodgkin disease in nodal metastases. Arch Pathol Lab Med. 2000 Mar; 124(3):446-9.
    View in: PubMed
    Score: 0.001
  345. Clinical care pathways: decreasing resource utilization in head and neck surgical patients. Otolaryngol Head Neck Surg. 1999 Dec; 121(6):755-9.
    View in: PubMed
    Score: 0.001
  346. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope. 1999 Jun; 109(6):970-5.
    View in: PubMed
    Score: 0.001
  347. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. Int J Radiat Oncol Biol Phys. 1999 May 01; 44(2):311-5.
    View in: PubMed
    Score: 0.001
  348. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers. Semin Radiat Oncol. 1999 Apr; 9(2 Suppl 1):97-101.
    View in: PubMed
    Score: 0.001
  349. Aggressive fibromatosis involving the cranial base in children. Neurosurgery. 1998 Nov; 43(5):1096-102.
    View in: PubMed
    Score: 0.001
  350. Image-guided fine-needle aspiration of the head and neck: five years' experience. Arch Otolaryngol Head Neck Surg. 1998 Oct; 124(10):1155-61.
    View in: PubMed
    Score: 0.001
  351. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998 Aug; 124(8):871-5.
    View in: PubMed
    Score: 0.001
  352. Can radiologists accurately predict preepiglottic space invasion with MR imaging? AJR Am J Roentgenol. 1997 Dec; 169(6):1681-7.
    View in: PubMed
    Score: 0.001
  353. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys. 1997 Aug 01; 39(1):127-35.
    View in: PubMed
    Score: 0.001
  354. Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997 Jan; 19(1):14-9.
    View in: PubMed
    Score: 0.001
  355. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck. 1996 Nov-Dec; 18(6):552-9.
    View in: PubMed
    Score: 0.001
  356. The vermilion-sharing graft for repairing a vermilionectomy defect. Plast Reconstr Surg. 1996 Oct; 98(5):876-9.
    View in: PubMed
    Score: 0.001
  357. Allergic fungal sinusitis: a clinicopathologic study of 16 cases. Hum Pathol. 1996 Aug; 27(8):793-9.
    View in: PubMed
    Score: 0.001
  358. Total midface reconstruction after radical tumor resection: a case report and overview of the problem. Ann Plast Surg. 1996 May; 36(5):551-7.
    View in: PubMed
    Score: 0.001
  359. Whole salivary flow rates following submandibular gland resection. Head Neck. 1996 May-Jun; 18(3):242-7.
    View in: PubMed
    Score: 0.001
  360. Anterior transcranial (craniofacial) resection of tumors of the paranasal sinuses: surgical technique and results. Neurosurgery. 1996 Mar; 38(3):471-9; discussion 479-80.
    View in: PubMed
    Score: 0.001
  361. Juvenile nasopharyngeal angiofibroma: an update of therapeutic management. Head Neck. 1996 Jan-Feb; 18(1):60-6.
    View in: PubMed
    Score: 0.001
  362. Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope. 1995 Nov; 105(11):1155-60.
    View in: PubMed
    Score: 0.001
  363. Outcome and complications of extended cranial-base resection requiring microvascular free-tissue transfer. Arch Otolaryngol Head Neck Surg. 1995 Nov; 121(11):1253-7.
    View in: PubMed
    Score: 0.001
  364. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 1995 Aug 15; 55(16):3604-9.
    View in: PubMed
    Score: 0.001
  365. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995 Jun 22; 64(3):196-201.
    View in: PubMed
    Score: 0.001
  366. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys. 1995 Jun 15; 32(3):619-26.
    View in: PubMed
    Score: 0.001
  367. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg. 1995 Feb; 112(2):252-7.
    View in: PubMed
    Score: 0.001
  368. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Arch Otolaryngol Head Neck Surg. 1995 Feb; 121(2):219-23.
    View in: PubMed
    Score: 0.001
  369. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys. 1994 Nov 15; 30(4):795-8.
    View in: PubMed
    Score: 0.001
  370. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg. 1994 Jul; 120(7):743-8.
    View in: PubMed
    Score: 0.001
  371. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. J Natl Cancer Inst. 1994 Jun 01; 86(11):859-61.
    View in: PubMed
    Score: 0.001
  372. Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer. 1994 May 15; 73(10):2563-9.
    View in: PubMed
    Score: 0.001
  373. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Head Neck. 1994 Jan-Feb; 16(1):39-44.
    View in: PubMed
    Score: 0.001
  374. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol. 1993 Oct; 11(10):1919-28.
    View in: PubMed
    Score: 0.001
  375. Salivary neoplasms of the palate: a flow cytometric and clinicopathological analysis. J Laryngol Otol. 1993 Sep; 107(9):858-61.
    View in: PubMed
    Score: 0.001
  376. Carcinomas of the lacrimal drainage system. Head Neck. 1993 Jul-Aug; 15(4):313-9.
    View in: PubMed
    Score: 0.001
  377. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993 Apr 30; 26(1):3-11.
    View in: PubMed
    Score: 0.001
  378. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer. Invest New Drugs. 1993 Feb; 11(1):57-60.
    View in: PubMed
    Score: 0.001
  379. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med. 1993 Jan 07; 328(1):15-20.
    View in: PubMed
    Score: 0.001
  380. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst. 1992 Feb 19; 84(4):235-41.
    View in: PubMed
    Score: 0.001
  381. Intratumoral DNA content heterogeneity in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1992 Feb; 118(2):169-73.
    View in: PubMed
    Score: 0.001
  382. Intraoral soft tissue reconstruction after cancer ablation: a comparison of the pectoralis major flap and the free radial forearm flap. Am J Surg. 1991 Oct; 162(4):397-9.
    View in: PubMed
    Score: 0.001
  383. Temporal bone involvement by prostatic adenocarcinoma: report of two cases and review of the literature. Head Neck. 1991 Jul-Aug; 13(4):349-54.
    View in: PubMed
    Score: 0.000
  384. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1339-45.
    View in: PubMed
    Score: 0.000
  385. Flow cytometric DNA content of adenoid cystic carcinoma of submandibular gland. Correlation of histologic features and prognosis. Arch Otolaryngol Head Neck Surg. 1990 Nov; 116(11):1291-6.
    View in: PubMed
    Score: 0.000
  386. Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer. 1990 Aug 01; 66(3):537-42.
    View in: PubMed
    Score: 0.000
  387. Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis. Prog Clin Biol Res. 1990; 339:179-91.
    View in: PubMed
    Score: 0.000
  388. Undifferentiated carcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol. 1990 Jan; 69(1):76-83.
    View in: PubMed
    Score: 0.000
  389. Transcranial resection of tumors of the paranasal sinuses and nasal cavity. J Neurosurg. 1989 Jul; 71(1):10-5.
    View in: PubMed
    Score: 0.000
  390. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope. 1988 Aug; 98(8 Pt 1):803-6.
    View in: PubMed
    Score: 0.000
  391. Oral cancer: a preventable disease? Tex Dent J. 1988 Jun; 105(6):8-11.
    View in: PubMed
    Score: 0.000
  392. Radiation therapy for carcinoma of the nasal vestibule. Otolaryngol Head Neck Surg. 1988 Jan; 98(1):67-71.
    View in: PubMed
    Score: 0.000
  393. Growth and progression of head and neck cancer: a report of the Upper Aerodigestive Cancer Task Force Workshop. Head Neck Surg. 1988 Jan-Feb; 10(3):179-86.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.